What does CUSIP 868459108 represent in this 13F holders report?

CUSIP 868459108 is the security identifier for SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock in Q2 2022?

214 institutional investors reported SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock for Q2 2022. Use the holders table for investor-level position and value details.

SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN)

CUSIP: 868459108

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / Common Stock
Shares outstanding: 57,572,193
Total 13F shares: 54,730,295
Share change: +1,506,971
Total reported value: $1,582,868,015
Put/Call ratio: 18%
Price per share: $28.92
Number of holders: 214
Value change: +$42,197,813
Number of buys: 106
Number of sells: 103

Quarterly Holders Quick Answers

What is CUSIP 868459108?
CUSIP 868459108 identifies SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP 868459108:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	15%	8,889,575	$287,311,000	—	31 Mar 2022	13F
VANGUARD GROUP INC	13F	Company	9.6%	5,538,820	$179,015,000	—	31 Mar 2022	13F
ARMISTICE CAPITAL, LLC	13F	Company	5.4%	3,100,000	$100,192,000	—	31 Mar 2022	13F
MACQUARIE GROUP LTD	13F	Company	4%	2,319,950	$74,981,000	—	31 Mar 2022	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	3.9%	2,221,320	$71,793,000	—	31 Mar 2022	13F
STATE STREET CORP	13F	Company	3.2%	1,844,139	$59,603,000	—	31 Mar 2022	13F
GW&K Investment Management, LLC	13F	Company	3.2%	1,827,091	$59,052,000	—	31 Mar 2022	13F
LOOMIS SAYLES & CO L P	13F	Company	2.8%	1,629,660	$52,670,000	—	31 Mar 2022	13F
Stephens Investment Management Group LLC	13F	Company	2.8%	1,601,344	$51,755,000	—	31 Mar 2022	13F
Aristotle Capital Boston, LLC	13F	Company	2.2%	1,258,067	$40,661,000	—	31 Mar 2022	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	2.2%	1,243,522	$40,191,000	—	31 Mar 2022	13F
ASHFORD CAPITAL MANAGEMENT INC	13F	Company	2%	1,124,405	$36,341,000	—	31 Mar 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.6%	930,007	$30,057,000	—	31 Mar 2022	13F
Polar Capital Holdings Plc	13F	Company	1.5%	877,945	$28,375,000	—	31 Mar 2022	13F
RICE HALL JAMES & ASSOCIATES, LLC	13F	Company	1.5%	854,949	$27,632,000	—	31 Mar 2022	13F
AMERIPRISE FINANCIAL INC	13F	Company	1.5%	847,315	$27,384,000	—	31 Mar 2022	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	1.5%	839,602	$26,919,000	—	31 Mar 2022	13F
FRONTIER CAPITAL MANAGEMENT CO LLC	13F	Company	1.1%	651,355	$21,052,000	—	31 Mar 2022	13F
NORTHERN TRUST CORP	13F	Company	1.1%	628,880	$20,326,000	—	31 Mar 2022	13F
Invesco Ltd.	13F	Company	1.1%	620,773	$20,064,000	—	31 Mar 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.96%	550,081	$17,779,000	—	31 Mar 2022	13F
Bank of New York Mellon Corp	13F	Company	0.95%	545,371	$17,626,000	—	31 Mar 2022	13F
INTERNATIONAL BIOTECHNOLOGY TRUST PLC	13F	Company	0.52%	297,500	$17,478,000	—	31 Mar 2022	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.9%	516,227	$16,684,000	—	31 Mar 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.88%	504,165	$16,295,000	—	31 Mar 2022	13F
Nuveen Asset Management, LLC	13F	Company	0.89%	514,392	$16,034,000	—	31 Mar 2022	13F
Epoch Investment Partners, Inc.	13F	Company	0.86%	495,115	$16,002,000	—	31 Mar 2022	13F
Woodline Partners LP	13F	Company	0.84%	485,412	$15,689,000	—	31 Mar 2022	13F
NORGES BANK	13F	Company	0.83%	475,134	$15,356,331	—	31 Mar 2022	13F
CONGRESS ASSET MANAGEMENT CO	13F	Company	0.81%	464,101	$15,000,000	—	31 Mar 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.7%	402,290	$13,003,000	—	31 Mar 2022	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.69%	394,796	$12,760,000	—	31 Mar 2022	13F
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income	13F	Company	0.66%	379,875	$12,278,000	—	31 Mar 2022	13F
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC	13F	Company	0.64%	366,292	$11,839,000	—	31 Mar 2022	13F
SCOUT INVESTMENTS, INC.	13F	Company	0.61%	348,764	$11,272,000	—	31 Mar 2022	13F
Tributary Capital Management, LLC	13F	Company	0.59%	336,846	$10,887,000	—	31 Mar 2022	13F
S&T BANK/PA	13F	Company	0.55%	316,326	$10,224,000	—	31 Mar 2022	13F
GLENMEDE TRUST CO NA	13F	Company	0.5%	290,217	$9,379,000	—	31 Mar 2022	13F
Soleus Capital Management, L.P.	13F	Company	0.44%	251,000	$8,112,000	—	31 Mar 2022	13F
MORGAN STANLEY	13F	Company	0.4%	232,704	$7,521,000	—	31 Mar 2022	13F
DEUTSCHE BANK AG\	13F	Company	0.4%	229,684	$7,423,000	—	31 Mar 2022	13F
Lisanti Capital Growth, LLC	13F	Company	0.39%	226,216	$7,311,000	—	31 Mar 2022	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.39%	224,892	$7,269,000	—	31 Mar 2022	13F
SEI INVESTMENTS CO	13F	Company	0.39%	223,149	$7,217,000	—	31 Mar 2022	13F
Bruce & Co., Inc.	13F	Company	0.39%	222,105	$7,178,000	—	31 Mar 2022	13F
Hennion & Walsh Asset Management, Inc.	13F	Company	0.35%	202,682	$6,551,000	—	31 Mar 2022	13F
RHUMBLINE ADVISERS	13F	Company	0.26%	148,330	$4,794,000	—	31 Mar 2022	13F
Legal & General Group Plc	13F	Company	0.26%	148,312	$4,794,000	—	31 Mar 2022	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.26%	147,469	$4,766,000	—	31 Mar 2022	13F
CW Advisors, LLC	13F	Company	0.25%	142,845	$4,617,000	—	31 Mar 2022	13F

Institutional Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN) as of Q2 2022

As of 30 Jun 2022, SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN) was held by 214 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 54,730,295 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, ARMISTICE CAPITAL, LLC, MACQUARIE GROUP LTD, DIMENSIONAL FUND ADVISORS LP, STATE STREET CORP, GW&K Investment Management, LLC, Stephens Investment Management Group LLC, LOOMIS SAYLES & CO L P, and RENAISSANCE TECHNOLOGIES LLC. This page lists 215 institutional shareholders reporting positions in this security for the Q2 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

220

Q2 2022 holders

214

Holder diff

-6

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 Value $	Q2 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.